Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 and reflecting a late stage of B cell differentiation close to plasma cell. Apart from viral infection, the pathogenesis of PEL is currently unclear. The aim of the present study was to investigate the role of antigen stimulation and selection in the evolution of PEL. In order to assess the specific variable heavy (V H ) and light (V L ) genes used by PEL and to define the heavy and light chain isotypes expressed by these lymphomas, immunoglobulin (Ig) genes from seven AIDS-related PEL were sequenced (three cell lines and four primary samples). Most of the samples (five out of seven) used lambda light chain genes; the majority of these (n = 4) belonged to the V lambda 3 family. Two cases expressed chains, whereas ␥ chains were found in two cases. In all cases, significant deviations from the presumed germline counterpart were found in both the expressed V H and V L genes. Statistical evidence for antigen selection was evident in four out of seven samples studied. Evidence for selection was more frequent in the light chain genes than in the heavy chain genes. Collectively, these data indicate that PEL originate from mature, antigen-experienced B cells and bear implications for the pathogenesis and histogenesis of this lymphoma.
Introduction
Primary effusion lymphoma (PEL) is a unique type of nonHodgkin's lymphoma recently defined as a distinct clinicopathologic entity. 1 The consistent infection by Kaposi's sarcoma associated herpes virus (KSHV), also termed human herpes virus 8 (HHV8) 2 and the growth in serious cavities in the absence of identifiable tumor masses distinguish PEL from other primary and secondary effusion lymphomas (reviewed in Ref. 3 ). PEL have been described mainly in AIDS patients. These lymphomas are rare in immunocompetent hosts, developing primarily in older age subjects. 4, 5 Although PEL do not produce significant amounts of Ig molecules and lack most B cell markers, molecular studies have indicated that these lymphomas derive from B cells reflecting a pre-plasma cell stage of differentiation. [6] [7] [8] Apart from infection by KSHV/HHV8, and frequently also by Epstein-Barr virus (EBV), 9 ,10 the pathogenesis of PEL is unclear. The sequence of the variable region of Ig genes may provide valuable information about the history of a B cell clone. For example, significant numbers of mutations have been found in the Ig V H and V L genes of Burkitt's lymphomas, 11, 12 follicular lymphomas, 13, 14 myelomas [15] [16] [17] and diffuse large cell lym-phomas. 18 Based upon these findings, it has been suggested that these neoplasms originate from B cells previously stimulated by antigen. In other instances, such as chronic lymphocytic leukemia, the same analysis has been helpful in evaluating the biology of this leukemia. 19, 20 The preferential use of V H and/or V L gene families or gene segments suggest restricted binding capacities for certain antigens or superantigens. Moreover, analyses of mutations of V H and V L genes may provide information on the pressure imposed by the stimulating antigen on the expanding clone.
In this study, the Ig V H and V L gene segments of seven AIDSrelated PEL samples derived from subjects with AIDS have been sequenced. The collective data are consistent with the notion that stimulation and selection by antigen occurred at the early stages of the evolution of the malignant clone.
Materials and methods

PEL samples
In this study, the PEL cell lines HBL6, BCBL 1 (obtained from the NIH Research and Reference Reagent Program), BC1 and BC2 (obtained from the American Type Culture Collection) were used. The cell lines BC1 and HBL6 were derived from the same patient though at different times and therefore in the text we will refer only to one of them (HBL6). These cell lines were derived from AIDS patients. 10, 21, 22 In addition, the study included cell samples of lymphomatous effusions collected at diagnosis from four patients with AIDS-PEL observed at the Centro di Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy. The features of the samples were reported elsewhere, including the assessment of their monoclonality as defined by Southern blotting analysis of Ig genes. Specifically, samples 842 and 1928 were described in Ref. 8 
Preparation of templates and conditions for PCR
Genomic DNA was purified by cell lysis followed by digestion with proteinase K, 'salting out' extraction and precipitation by ethanol. 25 Total RNA was isolated from cultured PEL cell lines or PEL patient samples using RNA Clean (TIB MolBiol, Genoa, Italy) according to the manufacturer's instructions. Two g of RNA were reverse transcribed to cDNA using M-MLV reverse transcriptase (GIBCO BRL, Life Technologies, Milan, Italy) primed by a randomly generated six-nucleotide primer. These reactions were carried out in 25 l using 50 pmoles of primer at 42°C for 1 h.
To determine the V H and V L gene nucleic acid sequence of the PEL samples, 0.3 g of DNA were amplified using a sense V H or V L leader family specific primer in conjunction with the appropriate antisense J H , J K or J ␥ primer. The V H and V K family specific primers used were previously reported. 20 V ␥ , J H , J K and J␥ primers used are reported in Table 1 . V␥ primers were specific for the different V ␥ leader sequences and were used admixing different primers in the same reaction as grouped in Table 1 . The primers specific for the genes encoding the constant portion of , ␥, ␣, kappa and lambda chain were previously described. 26, 27 The reaction was carried out in 50 l using 20 pmoles of each primer, 1.25 U of AmpliTaq DNA Polymerase (Perkin-Elmer, Cadriano di Granarolo Emilia (BO), Italy) and cycled with a Perkin-Elmer Cetus 480 apparatus (Perkin-Elmer) as follows: denaturation at 94°C for 45 s; annealing at 60°C for 30 s; and extension at 72°C for 30 s. After 35 cycles, extension was continued at 72°C for an additional 10 min. When cDNA was used as template, the reverse primers were specific for , ␥, or ␣ constant chains and the reaction was carried out for 45 cycles using AmpliTaq Gold (Perkin-Elmer). The reaction was preceded by a heating step of 10 min at 95°C to allow activation of AmpliTaq. The V H or V L PCR products were either sequenced directly after purification with Wizard PCR Preps (Promega, Madison, WI, USA), or cloned into TA vector (Invitrogen, San Diego, CA, USA) and then sequenced using an automated sequenator (PE Applied Biosystems, Italy). The rate of Taq misincorporation, evaluated in our laboratory, was between 1 bp every 600 or 800 bp depending on the conditions of amplification. 
Analyses of V H and V L sequences
Sequences obtained were compared with the V BASE sequence directory (Tomlinson et al, MRC Centre for Protein Engineering, Cambridge, UK) using MacVector 6.0.1 software (Oxford Molecular Group, Oxford, UK).
To evaluate the distribution of mutations among complementary determining region (CDR) and framework (FR) gene segments, two methods were used: replacement:silent (R:S) ratio 28 and the Chang-Casali binomial distribution model. 29 In this latter case, the number of expected R mutations was calculated using the formula R = n × CDR Rf (or FR Rf) × CDRrel (or FRrel) where n is the total number of observed mutations, Rf is the replacement frequency inherent to the CDR or FR, and CDRrel and FRrel are the relative sizes of these segments. Rf were calculated for each individual gene sequence using the InhsusCalc1.0 software, kindly provided by Dr Paolo Casali (Department of Pathology, Weill Medical College, Cornell University, NY, USA). A binomial probability model was used to evaluate whether the excess of R mutations in CDR or their scarcity in FR was due to chance. 29 Acidic and basic amino acids (aa) and H and L CDR3 charge, as defined by an estimated pI, was determined using the MacVector software program.
Results
Usage of H chain gene segments
Ig V genes were amplified from genomic DNA of PEL patient samples (842, 1899, 1912, 1928) and PEL cell lines (BC2, HBL6, BCBL1) using V H family specific primers and a constant J H primer mix and then separated by electrophoresis. A single PCR product was consistently detected in all of cell lines with the exception of BCBL1 for which no product was found. In the patient samples, there was usually a major PCR band (related to the malignant clone) and additional minor bands probably due to lesser numbers of normal B cell contaminants. While the PCR products from the cell lines could be directly sequenced, the major band from the patient samples had to be cloned before sequencing. For each patient two independent tests were carried out and each included the analysis of a minimum of six clones. These were invariably identical. Table 2 summarizes the data on the H chain gene segments used by PEL. The specific V H genes used were 3-23 (sample 1899), 3-73 (BC2 and sample 1928), 4-39 (sample 1912), 1-03 (sample 842) and 5-51 (HBL6). The D segment used could be confidently assigned in only one case (sample 1899). Analyses of J H gene segments revealed under-representation of the most commonly used J H 4 segment which was identified for certain in only one out of seven cases (sample 1912). For sample 842, it was impossible to distinguish between the usage of J H 4 and J H 5 gene segments. The Ig isotype produced by the PEL cells was assessed by RT-PCR in the cell lines and on the cell suspensions prepared from two patient samples (samples 1899 and 1928). For the remaining cases, such determination was not feasible due to the lack of sufficient material. Two cases (BC2 and sample 1899) used chains, and two cases (HBL6 and sample 1928) used ␥2 and ␥1 chains respectively (Table 2) . 
Usage of L chain gene segments
A productively rearranged V lambda gene was found in five out of seven PEL samples. BCBL1 and sample 1912 used the 3j gene, sample 1899 used the 31 gene and sample 842 used the 3 h gene of the lambda 3 gene family. Sample BC2 used the 2a2 gene of the V lambda 2 family. All of the samples used the J 2/J 3 segment. In all of the lambda-expressing PEL, a rearranged kappa chain gene was identified; sequence analyses revealed that these were non-productive rearrangements (not shown). In sample 1928, a non-productive rearranged kappa light chain gene was detected (not shown) suggesting the expression of lambda light chain by the malignant cells. However, PCR amplification using primers based on the available V lambda leader sequences 30 did not yield a product. HBL6 was the only PEL sample with a productively rearranged kappa gene (Table 2 ). This rearrangement was consistently amplified from DNA, using the V K 4 family specific primer in conjunction with a reverse J K primer, whereas attempts to show the rearrangement on cDNA using a reverse primer specific for the constant portion of kappa chain (C K ) consistently failed (not shown). Figures 1 and 2 show the deduced amino acid sequences of the V H and V L genes used by PEL (nucleotide sequences are submitted in GenBank under accession numbers AJ006161, AJ006162, AJ6164-AJ006173). When the sequences were compared with a database of V H and V L germline sequences (V BASE Sequence Directory, Tomlinson et al, MRC Centre for Protein Engineering, Cambridge, UK), differences from the most likely germline counterparts were observed (Figure 1 ). The distribution of these mutations was subsequently analyzed using the classical R:S ratio 28 and the binomial distribution model of Chang and Casali. 31 A difference between the R:S ratio in the CDR and that in the FR of у3 suggests antigen selection. The distribution of mutations can also be analyzed using the algorithm generated by Chang-Casali that takes into account inherent susceptibility of replacement mutations in individual genes. 31 The R:S ratio for the V H genes are reported in Table 2 . In two cases (BC2 and 842), the R:S ratios for the various V H was у3. When the Chang-Casali algorithm was applied to the V H gene sequences, a significant value (P Ͻ 0.05) was found in the CDR of sample 842. In addition, significant values were found in the FR regions of samples HBL6, 842, 1899, 1912, 1928 .
Somatic mutations of V H and V L genes
A preferential clustering of R mutations in the CDR was observed more often in the V L chain. The R:S ratio of V L genes was у3 in four of six samples (BC2, HBL6, BCBL1 and 1912). Significant values were observed with the Chang-Casali analysis in the CDR of samples BC2, HBL6 and 1912.
By combining the H and L chain analyses, indication of antigen selection was obtained in five out of seven cases (BC2, 842, BCBL1, HBL6 and 1912) according to the R:S ratio and in four out of seven samples (842, BC2, HBL6 and 1912) if the Chang-Casali algorithm was considered. Table 3 shows the aminoacid (aa) composition of H and L CDR3. Negatively charged aa were present in the HCDR3 in all but one of the samples (HBL6). These included the aspartic acid encoded by the J H portion of the CDR3, and other negatively charged aa. The average of the calculated pI of HCDR3 was 4.11 while decreased to 3.54 when excluding the HBL6 case. In this sample, the presence of an arginine and a histidine raised the pI to 7.00.
CDR3 composition
The features of the LCDR3 were more heterogeneous. Length varied from nine aa (1912 and HBL6) to 11 (842 and 1928). There were no examples of positively charged LCDR3.
Figure 1
Amino acid sequences of expressed PEL V H genes. The deduced aa sequence of the indicated PEL cases is shown and compared to the corresponding germline V H sequences. Upper cases represent replacement mutations; lower cases represent silent mutations.
Figure 2
Amino acid sequences of expressed PEL V L genes. The deduced aa sequence of the indicated PEL cases is shown and compared to the corresponding germline V L sequences. Upper cases represent replacement mutations, lower cases represent silent mutations. In bold face are indicated acidic residues; in italic and underlined are indicated basic residues.
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Discussion
The present study was undertaken with the specific aim of gathering information on the clonal evolution of PEL. To this end, the V H and V L gene usage by the malignant cells as well as structural details of these genes or those encoding the antibody CDR3 was investigated.
A comparison of the Ig V gene repertoire expressed by seven PEL with that of normal B cells disclosed an overuse of lambda light chain (five of seven samples). Although no productive light chain rearrangements could be determined for case 1928, the presence of a non-productive kappa rearrangement suggested the expression of lambda light chain also in this sample, thus possibly raising the total value of lambda expressing cases to six of seven. The predominance of lambda light chain was not apparent in previous reports on PEL. 1, 6 However, it should be noted that these studies utilized Southern blotting that can generate ambiguous data when lambda light chain rearrangements are evaluated, primarily due to the presence of several bands in the lambda light chain locus already in the germline configuration. 32 Moreover, in contrast to PCR methodologies, Southern blotting cannot distinguish between productive and non-productive rearrangements. The present data suggest a selection for lambda light chain, possibly operated by antigen and/or superantigen stimulation, although a larger number of samples must be analyzed to confirm these data. This concept is in line with the observation that four of the five sequenced lambda genes belonged to the V L 3 family. Information regarding the use of V lambda gene families in normal individuals are rare and controversial. 33, 34 However, a recent report 35 confirms previous molecular studies 33 showing that V lambda 3 family genes are not commonly found among the productive rearrangements of B cells deriving from normal individuals. In some pathological circumstances, preferential use of V lambda 3 family genes has been described. 36, 37 Moreover, conditions favoring lambda light chain expression have been reported in patients with AIDS. [38] [39] [40] The V H and V L gene sequences consistently revealed significant deviations from the germline V H and V L genes. Although some of the detected nucleotide changes may be due to genetic polymorphisms, [41] [42] [43] most of them likely represented somatic mutations. Analyses of the mutation patterns indicated not only stimulation, but also selection by antigen, based on the accumulation of R mutations on CDR in most of the cases (see Table 2 ). The distribution of the observed R mutations suggested that antigen selection occurred more frequently in the V L than in the V H genes. For example, of the four cases that met the Chang-Casali criteria for antigen selection, three were selected in the V L (HBL6, BC2, and 1912) and not in the V H gene and one case in the V H gene (842). These data, along with the lambda light chain predominance, suggested a special importance for the V lambda genes in PEL development. Our data expand and corroborate the previous suggestion that antigen might have a role in PEL development. 44 In that group of samples evidence for antigen selection was evident in the V H genes in the majority of cases. In this respect, our samples differ from that group. However, since V L chains were not analyzed we do not know whether suggestion of antigen selection was also present on these genes.
Given the impossibility to determine the presence of mutations in the HCDR3, we have chosen to evaluate two features of this region such as the estimated pI and the aa length. These features are not indicative of antigen selection per se, but might indicate common characteristics among the aa stretches that contribute to shape this region. These criteria have been used previously for this purpose. 20, 27 These analyses disclosed that there was a prevalence of negatively charged aa which made the calculated pI of this region low in four out of five cases. In one case (HBL6) this value raised to 7.00. This was the only sample with a productive rearrangement for kappa light chain, possibly suggesting a different mode of antigen selection for this clone. Another feature of HCDR3 was a rather short length (average 12.3 ± 2.8 aa). It has been reported that normal, IgM+memory B cells exhibit significantly shorter HCDR3 than virgin B cells. 45 Although the relatively small number of PEL examined does not allow statistical comparison with the data on normal B cells, the short length of HCDR3 would be consistent with the notion that PEL cells are antigen experienced cells.
The H chain isotype could be determined in four out of seven samples. Of these, two expressed a isotype and the other two expressed the ␥1 and ␥2 isotypes, respectively. This observation implies that ␥-producing PEL cells are antigen experienced since the isotype switch takes place preferentially during antigenic stimulation in the presence of T cell help and cytokines. 46 Interestingly, typing of the same PEL specimens for Ig classes with methods different from PCR (ie immunofluorescence or immunochemistry on tissue samples) showed little (approximately 1% of cells) or no expression of Ig molecules (not shown). This finding is consistent with the hypothesis that, in PEL, production and/or secretion of Ig is decreased or even stopped at a certain point of lymphomagenesis.
In two cases (BCBL1 and 1928) we have not been able to amplify the V H or the V L gene. In another case (HBL6), we failed to amplify V kappa cDNA although the rearrangement was evident when amplifying the DNA. The status of the kappa constant region, in this cell line was not further characterized because this issue was beyond the aim of the study. These data might indicate the loss of Ig gene portions and, in part, offer an explanation for both absence of Ig gene expression and difficulties in finding Ig gene rearrangements in some instances. 10 However, since selection of mutated V H and V L genes requires expression of intact Ig molecules, the finding of such mutated genes in PEL suggests that inability to express Ig molecules is a late event, possibly connected with other transforming changes during lymphomagenesis.
Sequencing of several molecular clones (10 clones for every sample) obtained from the PCR product of the V H gene of sample 842 and the V L gene of sample 1899 failed to indicate presence of intraclonal diversification (not shown). Although the small number of samples analyzed does not allow a definitive conclusion, the apparent lack of intraclonal divergence in the samples analyzed is consistent with the notion that malignant transformation occurred following antigen stimulation and selection and prevented subsequent mutations. This is analogous to the pattern reported for B-CLL cells. 26, [47] [48] [49] In support of this conclusion are the findings that two PEL cell lines (HBL6 and BC1), which had been derived at different times from the same PEL patient, expressed identical V H and V L segments. In the recent study previously mentioned, 44 intraclonal divergence was found in one case out of the five analyzed thus confirming the notion that PEL commonly derive from post-germinal center B cells, although exceptions may exist.
Collectively, the above data indicate that PEL derive from antigen-experienced B cells that possibly have undergone a number of transforming changes during and/or following the initial antigenic stimulation. This notion may be relevant in the setting of AIDS since these patients have a high load of pathogens. 50 Therefore, antigen stimulation may have a promoting role in the pathogenesis of PEL. In this respect, the mechanisms of PEL lymphomagenesis has a number of similarities with that of other AIDS-related lymphomas. [51] [52] [53] [54] 
